Skip to main content
NIH funding notice PA-12-091

New Technologies for Viral Hepatitis STTR (R41/R42)

Closed on December 19, 2014.

Posted
January 31, 2012
Close date
December 19, 2014
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $149,156 in first-year total cost, median $149,156.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 IDM-U (10)]1

Most frequent institutions

  1. VIOGEN BIOSCIENCES, LLC1
Competing awards under PA-12-091 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2014Hepatitis C Virus RNA-Targeted Therapeutics1R41AI108104-01A1BAJJI, ASHOKDAVIS, DARRELL RVIOGEN BIOSCIENCES, LLC, UT$149,156ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.